Total assets decreased 39.1%
Total assets changed -39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed -39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -43.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +27.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +82.9% from the comparable as-filed period.
Operating margin changed +1835 basis points from the comparable as-filed period.
Cash & equivalents changed -71.7% from the comparable as-filed period.
Shares outstanding changed +4.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Gross margin changed +373 basis points from the comparable as-filed period.
Current liabilities changed -65.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed +15.7% from the comparable as-filed period.
SBC / revenue changed -850 basis points from the comparable as-filed period.
Stock-based compensation changed -40.4% from the comparable as-filed period.
Gross profit changed +21.6% from the comparable as-filed period.
Working capital / assets changed +1748 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Receivables / revenue changed +500 basis points from the comparable as-filed period.
Current ratio changed +60.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory / revenue changed -239 basis points from the comparable as-filed period.
Operating cash flow changed +10.2% from the comparable as-filed period.
R&D / revenue changed -227 basis points from the comparable as-filed period.
Working capital changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +5.5% from the comparable as-filed period.
Capital expenditure changed +22.4% from the comparable as-filed period.
Research & development changed +7.5% from the comparable as-filed period.
Capex / revenue changed +20 basis points from the comparable as-filed period.
Free-cash-flow margin changed -78 basis points from the comparable as-filed period.
Inventory changed +3.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed -0.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed -58 basis points from the comparable as-filed period.
Current ratio changed +100.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +73.3% from the comparable as-filed period.
Total assets changed -36.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed +1913 basis points from the comparable as-filed period.
Cash & equivalents changed -37.4% from the comparable as-filed period.
Shares outstanding changed +4.2% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Gross margin changed +372 basis points from the comparable as-filed period.
Current liabilities changed -70.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current assets changed -41.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +15.6% from the comparable as-filed period.
Working capital changed +25.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -720 basis points from the comparable as-filed period.
Gross profit changed +21.4% from the comparable as-filed period.
Free-cash-flow proxy changed +105.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Stock-based compensation changed -34.9% from the comparable as-filed period.
R&D / revenue changed -713 basis points from the comparable as-filed period.
Operating cash flow changed +151.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital / assets changed +2576 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed -262 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -232 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1446 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1415 basis points from the comparable as-filed period.
Capital expenditure changed +26.1% from the comparable as-filed period.
Trade receivables changed +10.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -7.9% from the comparable as-filed period.
Inventory changed +5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +31 basis points from the comparable as-filed period.
Cost of revenue changed -0.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.